|
Persistent Post-Viral State of Bacterial Pneumonia Susceptibility and Severity in Down Syndrome |
5R01AI141662-04 |
|
NIAID |
2022 |
|
The effectiveness of RSV immunoprophylaxis on the short- and long- term respiratory morbidity in children with Down syndrome |
5R01AI143710-04 |
|
NIAID |
2022 |
|
Dissecting the impact of interferon hypersensitivity on mouse models of Down syndrome |
5R01AI145988-04 |
|
NIAID |
2022 |
|
Mediator kinases as interferon antagonists in Down Syndrome |
5R01AI156739-03 |
|
NIAID |
2022 |
|
The Impact of Maternal CMV Infection on Birth Outcomes |
5R03AI151426-02 |
|
NIAID |
2022 |
|
Role of IFNs and IFNGR in susceptibility to bacteria in Down syndrome |
5R21AI161827-02 |
|
NIAID |
2022 |
|
Epigenetic and transcriptional consequences of Intellectual Disability-associated mutations in the histone lysine demethylase KDM5. |
1F31GM146347-01 |
|
NIGMS |
2022 |
|
Molecular basis of fatty acid transport by peroxisomal ABC transporters |
1R01GM146906-01 |
|
NIGMS |
2022 |
|
Alternative Splicing Modulates the Activity of CaV3.1, an Ion Channel Gene Involved in Spinocerebellar Ataxia, Epilepsy, and Autism Spectrum Disorders. |
1R15GM148923-01 |
|
NIGMS |
2022 |
|
The Role of Sympathetic Nervous System Activity on Blood Pressure Regulation in Individuals with Autism Spectrum Disorder |
1SC2GM144165-01 |
|
NIGMS |
2022 |